Style | Citing Format |
---|---|
MLA | Mehryab F, et al.. "Exosomes As Cutting-Edge Therapeutics in Various Biomedical Applications: An Update on Engineering, Delivery, and Preclinical Studies." Biochimie, vol. 213, no. , 2023, pp. 139-167. |
APA | Mehryab F, Taghizadeh F, Goshtasbi N, Merati F, Rabbani S, Haeri A (2023). Exosomes As Cutting-Edge Therapeutics in Various Biomedical Applications: An Update on Engineering, Delivery, and Preclinical Studies. Biochimie, 213(), 139-167. |
Chicago | Mehryab F, Taghizadeh F, Goshtasbi N, Merati F, Rabbani S, Haeri A. "Exosomes As Cutting-Edge Therapeutics in Various Biomedical Applications: An Update on Engineering, Delivery, and Preclinical Studies." Biochimie 213, no. (2023): 139-167. |
Harvard | Mehryab F et al. (2023) 'Exosomes As Cutting-Edge Therapeutics in Various Biomedical Applications: An Update on Engineering, Delivery, and Preclinical Studies', Biochimie, 213(), pp. 139-167. |
Vancouver | Mehryab F, Taghizadeh F, Goshtasbi N, Merati F, Rabbani S, Haeri A. Exosomes As Cutting-Edge Therapeutics in Various Biomedical Applications: An Update on Engineering, Delivery, and Preclinical Studies. Biochimie. 2023;213():139-167. |
BibTex | @article{ author = {Mehryab F and Taghizadeh F and Goshtasbi N and Merati F and Rabbani S and Haeri A}, title = {Exosomes As Cutting-Edge Therapeutics in Various Biomedical Applications: An Update on Engineering, Delivery, and Preclinical Studies}, journal = {Biochimie}, volume = {213}, number = {}, pages = {139-167}, year = {2023} } |
RIS | TY - JOUR AU - Mehryab F AU - Taghizadeh F AU - Goshtasbi N AU - Merati F AU - Rabbani S AU - Haeri A TI - Exosomes As Cutting-Edge Therapeutics in Various Biomedical Applications: An Update on Engineering, Delivery, and Preclinical Studies JO - Biochimie VL - 213 IS - SP - 139 EP - 167 PY - 2023 ER - |